Cairnhill Investments (Mauritius) Pte Ltd
CIK 1434871 · last filed 2017-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PTLA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
THE ATRIUM@ORCHARD
SINGAPORE, U0 238891
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMYRIS, INC. (AMRS) Delisted | 10%+ Owner | 3,455,214 | $0.05 | $172.8K | -$22.66M | 18 | 2017-04-03 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | 10%+ Owner | 5,833,568 | — | — | $166.40M | 1 | 2014-10-08 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-10 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −4,291,388 | -$3.48M | EDGAR |
| 2016-12-13 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −217,144 | -$173.8K | EDGAR |
| 2016-11-18 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −2,039,116 | -$1.64M | EDGAR |
| 2016-10-18 | AMYRIS, INC. (AMRS) Delisted | Sell (S) | −9,200,000 | -$7.65M | EDGAR |
| 2015-12-11 | AMYRIS, INC. (AMRS) Delisted | Exer (X) | +50,800,976 | $508.0K | EDGAR |
| 2014-10-08 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Buy (P) | +6,400,000 | $166.40M | EDGAR |
| 2014-01-17 | AMYRIS, INC. (AMRS) Delisted | Buy (P) | — | $0 | EDGAR |
| 2013-10-21 | AMYRIS, INC. (AMRS) Delisted | Buy (P) | — | $0 | EDGAR |
| 2013-10-18 | AMYRIS, INC. (AMRS) Delisted | Buy (P) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.